Live Breaking News & Updates on Optimizing Therapeutics

Stay updated with breaking news from Optimizing therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novartis, GSK team up for $3.6m genetic diversity research in Africa

Novartis, GSK team up for $3.6m genetic diversity research in Africa
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Lutz Hegemann , Pauline Williams , Global Health Pharma , Steering Committee , Novartis Global Health , Africa Genomic Research Approach For Diversity , African Medical Research Council , Africa Genomic Research Approach , Optimizing Therapeutics , Project Africa , Global Health , South African Medical Research Council , Joint Steering Committee , Health Pharma , Cadent Therapeutics , லூட்ஸ் ெகேமன்ன் , பாலீந் வில்லியம்ஸ் , உலகளாவிய ஆரோக்கியம் பார்மா , திசைமாற்றி குழு , நோவர்த்திச் உலகளாவிய ஆரோக்கியம் , மேம்படுத்துகிறது சிகிச்சை , உலகளாவிய ஆரோக்கியம் , கூட்டு திசைமாற்றி குழு , ஆரோக்கியம் பார்மா ,

Novartis and GSK announce collaboration to support scientifi

ng
Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis (TB).
1
Lutz Hegemann, M.D., Chief Operating Officer for Global Health at Novartis said: “Novartis has a long-standing commitment to improving and extending the lives of patients around the world. Our efforts include seeking innovative ways to improve the standard of care where possible. This is why we are excited by this important collaboration on scientific research on genetic diversity in Africa. It has the potential to improve the efficacy and tolerability of current and future medicines, starting with two of the most deadly diseases, malaria and tuberculosis. In alignment with our ongoing efforts to strengthen scientific capabilities in lower-resource settings, this project also provides op ....

United States , Isabella Zinck , Eric Althoff , Thomas Hungerbuehler , Kara Cournoyer , Glenda Gray , Samir Shah , Lutz Hegemann , Sloan Simpson , Katerina Kontzalis , Antonio Ligi , Pauline Williams , Novartis Global Health Corporate Responsibility , Global Health Pharma , Novartis Institutes For Biomedical Research , Novartis Institutes For Biomedical Research On African , Steering Committee , Global Health At Novartis , Global Health Cr Communications , Novartis Us External Communications , Novartis External Communications , Exchange Commission , Africa Medical Research Council , African Medical Research Council , Africa Genomic Research Approach For Diversity , Project Africa Genomic Research Approach ,